GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » Financial Strength

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Financial Strength : 1 (As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Financial Strength?

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T has the Financial Strength Rank of 1. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.

Warning Sign:

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T displays poor financial strength. Usually, this is caused by too much debt for the company.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T did not have earnings to cover the interest expense. As of today, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Altman Z-Score is 0.00.


Competitive Comparison of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength falls into.



Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Interest Expense for the months ended in . 20 was TND0.00 Mil. Its Operating Income for the months ended in . 20 was TND0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was TND0.00 Mil.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Interest Coverage for the quarter that ended in . 20 is

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T had no long-term debt (1).

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Debt to Revenue Ratio for the quarter that ended in . 20 is

Debt to Revenue Ratio=Total Debt (Q: . 20 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=( + ) / 0
=N/A

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T has a Z-score of 0.00, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T has the Financial Strength Rank of 1. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Financial Strength Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Business Description

Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Headlines

No Headlines